0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Estimating Mortality Associated With Antipsychotics and Other Psychotropics

Roberto Lozano, PhD1
[+] Author Affiliations
1Hospital Real de Nuestra Señora de Gracia, Zaragoza, Zaragoza, Spain
JAMA Psychiatry. 2015;72(10):1057. doi:10.1001/jamapsychiatry.2015.0669.
Text Size: A A A
Published online

Extract

To the Editor In their article, Maust et al1 concluded that the absolute effect of antipsychotics on mortality in elderly patients with dementia may be higher than previously reported. To assess this, they compared the estimated mortality risk associated with each antipsychotic agent (eg, haloperidol, risperidone, olanzapine, and quetiapine) among patients affected by dementia with the mortality risk in a cohort of nondrug users and a cohort of antidepressant drug users, both affected by dementia as control groups.

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

October 1, 2015
Donovan T. Maust, MD, MS; Lon S. Schneider, MD, MS; Helen C. Kales, MD
1Department of Psychiatry, University of Michigan, Ann Arbor2Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan
3Department of Psychiatry, University of Southern California, Los Angeles
JAMA Psychiatry. 2015;72(10):1058. doi:10.1001/jamapsychiatry.2015.0675.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

647 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();